Scientific Program
The oral sessions of the 2nd International Caparica Conference in Antibiotic Resistance brought together speakers addressing the selection factors behind antimicrobial resistance in human and veterinary medicine. Below is the list of oral contributors, together with the country of affiliation stated on the conference website.
Oral Contributors
Contributors and their affiliations as listed for the 2017 scientific program.
| Speaker | Affiliation |
|---|---|
| Dr. Elisabeth Grohmann | Germany |
| Dr. Marcos Quintela Baluja | UK |
| Dr. Adelaide Almeida | Portugal |
| Dr. Max Maurin | |
| Dr. Thomas Schwartz | |
| Dr. Ashraf Hakim | |
| Dr. Frank Schweizer | |
| Dr. Keith Poole | |
| Dr. Christian Melander | |
| Dr. Mingdi Yan |
Note on the list
Countries are shown where the conference website stated them for the contributor. Keynote speakers are presented separately, on the Scientific Program pages of the conference site.
The oral contributions programme of the 2nd International Caparica Conference in Antibiotic Resistance brought together researchers from a wide range of countries and institutions, each presenting work on the forces shaping antimicrobial resistance. Presenters addressed the clinical and agricultural drivers of resistance emergence, including antibiotic use in human medicine, veterinary practice, and food production systems, and discussed how resistant bacteria and resistance genes move between human and animal populations.
Several contributions focused on the mechanisms underlying resistance, exploring how pathogens acquire and spread resistance determinants and how this knowledge can be applied to surveillance and diagnostic strategies. Other sessions considered the epidemiological dimensions of the problem, including transmission patterns across hospitals and communities, the influence of movement and migration on the spread of resistant strains, and the contribution of environmental sources to the widening pool of resistant organisms.
Speakers also examined the broader scientific pipeline, from drug discovery and the development of novel antimicrobial agents to the use of proteomic approaches in understanding bacterial behaviour and resistance phenotypes. The conference emphasised collaboration between clinicians, microbiologists, veterinarians and public health authorities, and highlighted how shared surveillance data and coordinated national policies can slow the worldwide emergence of resistance and reduce the burden of resistant infections.
The conference served as a platform for exchanging results, debating methodological approaches, and identifying research priorities, with contributions spanning laboratory investigation, clinical observation and population-level analysis. Discussions touched on the responsible use of antibiotics, the role of regulation and stewardship programmes, and the need for sustained funding of research, so that practical strategies to overcome resistance can be implemented in health systems worldwide.
Organised around plenary sessions, invited and contributed oral presentations, and poster communication, the scientific programme allowed detailed exploration of resistance in both human and veterinary contexts. The meeting aimed to stimulate new approaches and partnerships, giving participants an opportunity to present findings, receive critical feedback, and build networks with colleagues working across microbiology, epidemiology, and public health.
Programme overview
Review the full scientific program, including keynotes, oral contributions, poster contributions and the conference schedule.
Back to Program